Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Plena is a Brazilian women’s health tool launched by Origo Tecnologia LTDA, aimed at women aged 30–65. It covers topics such as fatigue, perimenopause/menopause, sleep, mental health, cardiovascular health, breast health, bone health, nutrition, hormone therapy, and GLP-1. It is clearly positioned as an education and self-tracking platform, not a medical service: it does not diagnose, prescribe, or replace a doctor.
The core feature is “Sinais & Gatilhos”: users spend about 30 seconds a day logging symptoms and triggers, such as poor sleep, alcohol, coffee, stress, cycle phase, medications, and more. The system cross-references these inputs and highlights personal patterns. Plena also manages scales or risk calculators such as PHQ-9, GAD-7, MRS, PSQI, FRAX, Framingham, and Gail, and generates doctor-readable PDF consultation reports. On the AI side, Plena IA is a PT-BR conversational assistant for discussing perimenopause-related topics; however, the page does not disclose the underlying model or validation metrics, and it warns that answers may be inaccurate.
The page lists Free, monthly R$49, quarterly R$99, annual R$294, and a limited founder lifetime access plan at R$997. Paid subscriptions are said to come with no charge for the first 14 days, one-click cancellation, and the option to pause for 3 months each year. Note that the legal terms list Premium pricing as R$47/month or R$470/year, which does not fully match the marketing page.
The strengths are its focused use case, clear medical boundaries, obvious value in consultation reports, and stated AES-256 encryption at rest plus LGPD compliance. The drawbacks are that the product is still in pre-launch/early-stage status, with some features being rolled out gradually; AI capabilities are not sufficiently disclosed; information on Chinese language support, APIs, and third-party integrations is missing; and health recommendations still need to be interpreted by a doctor.
It is better suited to users in Portuguese-speaking environments who want to track long-term changes in women’s health and bring structured data to medical appointments, especially those in perimenopause or menopause. It is not suitable for people expecting AI to directly diagnose or prescribe medication. Access from mainland China is not mentioned in the text, so it is assessed as unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on useplena.com.br official site.
useplena.com.br is an Brazil Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach useplena.com.br directly.